Bethesda, MD
Collaborative
The National Cancer Institute (NCI) is developing a national repository of Patient-Derived Models (PDMs) comprised of patient-derived xenografts (PDXs), patient-derived organoids (PDOrg) and in vitro patient-derived tumor cell cultures (PDCs) and cancer associated fibroblasts (CAFs). Read More...